Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Probiotec.
RELATED STOCKHEAD STORIES
News
Market Highlights and 5 ASX Small Caps to watch on Wednesday
Health & Biotech
ScoPo’s Powerplays: Biogen drama, M&A action, and profit-taking coloured the week in healthcare
News
Market Highlights and 5 ASX Small Caps to watch on Wednesday
Experts
Microcap magic: From iron ore to edtech (and IPOs) with Annapurna’s Stephen Scott
News
10 at 10: These ASX stocks are the focal point this morning – thanks to the Pfizer vaccine news
Health & Biotech
The pandemic could be a watershed moment for wellness products
Health & Biotech
Health: Wheeler dealer Probiotec spending money to make money
Health & Biotech
When your guts have gone nuts, who do you call? These ASX stocks are fighting gastrointestinal disease
Health & Biotech
Health: GTG back in with breast cancer, hopes to start sales next year
News
Trading Places: More investors follow WiseTech founder into Kyckr
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Probiotec shares just hit their highest point in nearly a decade
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Probiotec made a $12.9m half-year profit but 91pc of it was from businesses it has sold
Health & Biotech
Diet shake maker Probiotec forecasts fatter profits
Health & Biotech
